Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
Defining functional changes in the brain caused by targeted stereotaxic radiosurgery.
Protein 4.1R attenuates autoreactivity in experimental autoimmune encephalomyelitis by suppressing CD4(+) T cell activation.
Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?
MerTK Is a Functional Regulator of Myelin Phagocytosis by Human Myeloid Cells.
Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Is there a cognitive signature for MS-related fatigue?
Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
TRANSGLUTAMINASE 2 IS INVOLVED IN HOMOCYSTEINE-INDUCED ACTIVATION OF HUMAN THP-1 MONOCYTES.
Demyelinating disease: CSF analysis could aid prediction of conversion from optic neuritis to multiple sclerosis in children.
Mast Cell and Autoimmune Diseases.
Neurology of inherited glycosylation disorders.
[Treatment of neuromyelitis optica].
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis.
Endogenous Two-Photon Excited Fluorescence Provides Label-Free Visualization of the Inflammatory Response in the Rodent Spinal Cord.
Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
Pages
« first
‹ previous
…
541
542
543
544
545
546
547
548
549
…
next ›
last »